Please login to the form below
Healthcare terms - L
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Healthcare terms - L
- Labelling
- Ladder of loyalty
- Latent click through
- Latent demand
- Launch
- Launch plan
- Layout
- Lead generation
- Lead management
- Leader article
- Leader pricing
- Learning curve
- Learning log
- License (product)
- License agreement
- Licensed
- Life cycle (product)
- Lifestyle
- Lifestyle drug
- Lifestyle research
- Likert scale
- Line extension
- List broker
- List building
- List price
- Literature search
- Loaded question
- Lobby
- Lobby firm
- Local advertising
- Logistics
- Logo
- Long term value (LTV)
- Long-range planning
- Loss leader
Featured jobs
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- FDA rejects Sarepta’s new Duchenne drug over safety fears
- Novo Nordisk shareholder revolt reaches Europe
- AstraZeneca buys FDA priority review voucher from Sobi
- Behaviour change – is there something missing?
- BeiGene gets speedy US review for lymphoma drug zanubrutinib
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
- Pfizer goes big on gene therapy with $500m facility spend
- Empowered patients: shaking the foundations of healthcare
Quick links
Infographics
